Fukui Sho, Ooyama Norihiko, Tamura Jun, Umar Mohammed Ahmed, Ishizuka Tomohito, Itami Takaharu, Miyoshi Kenjiro, Sano Tadashi, Yamashita Kazuto
Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8591, Japan.
J Vet Med Sci. 2017 Mar 18;79(3):502-508. doi: 10.1292/jvms.15-0666. Epub 2017 Jan 21.
Maropitant, a neurokinin-1 receptor antagonist, may provide analgesic effects by blocking pharmacological action of substance P. Carprofen is a non-steroidal anti-inflammatory drug commonly used for pain control in dogs. The purpose of this study was to evaluate the effect of a combination of maropitant and carprofen on the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs. Six healthy adult beagle dogs were anesthetized with sevoflurane four times with a minimum of 7-day washout period. On each occasion, maropitant (1 mg/kg) alone, carprofen (4 mg/kg) alone, a combination of maropitant (1 mg/kg) and carprofen (4 mg/kg), or saline (0.1 ml/kg) was subcutaneously administered at 1 hr prior to the first electrical stimulation for the sevoflurane MAC-BAR determination. The sevoflurane MAC-BAR was significantly reduced by maropitant alone (2.88 ± 0.73%, P=0.010), carprofen alone (2.96 ± 0.38%, P=0.016) and the combination (2.81 ± 0.51%, P=0.0003), compared with saline (3.37 ± 0.56%). There was no significant difference in the percentage of MAC-BAR reductions between maropitant alone, carprofen alone and the combination. The administration of maropitant alone and carprofen alone produced clinically significant sparing effects on the sevoflurane MAC-BAR in dogs. However, the combination of maropitant and carprofen did not produce any additive effect on the sevoflurane MAC-BAR reduction. Anesthetic premedication with a combination of maropitant and carprofen may not provide any further sparing effect on anesthetic requirement in dogs.
马罗匹坦是一种神经激肽-1受体拮抗剂,它可能通过阻断P物质的药理作用来提供镇痛效果。卡洛芬是一种非甾体抗炎药,常用于犬类的疼痛控制。本研究的目的是评估马罗匹坦和卡洛芬联合使用对犬七氟醚抑制肾上腺素能反应的最低肺泡浓度(MAC-BAR)的影响。六只健康成年比格犬用七氟醚麻醉四次,每次之间至少有7天的洗脱期。每次麻醉时,在首次进行七氟醚MAC-BAR测定的电刺激前1小时,分别皮下注射单独的马罗匹坦(1mg/kg)、单独的卡洛芬(4mg/kg)、马罗匹坦(1mg/kg)和卡洛芬(4mg/kg)的组合或生理盐水(0.1ml/kg)。与生理盐水组(3.37±0.56%)相比,单独使用马罗匹坦(2.88±0.73%,P=0.010)、单独使用卡洛芬(2.96±0.38%,P=0.016)以及联合使用(2.81±0.51%,P=0.0003)均能显著降低七氟醚MAC-BAR。单独使用马罗匹坦、单独使用卡洛芬和联合使用组之间MAC-BAR降低的百分比没有显著差异。单独使用马罗匹坦和单独使用卡洛芬对犬七氟醚MAC-BAR产生了临床上显著的节省效应。然而,马罗匹坦和卡洛芬联合使用对七氟醚MAC-BAR降低并没有产生任何相加作用。马罗匹坦和卡洛芬联合进行麻醉前用药可能不会对犬的麻醉需求提供进一步的节省效应。